|
LICENSE AGREEMENTS (Details Textual) (USD $)
|
1 Months Ended | 12 Months Ended | |
|---|---|---|---|
|
Sep. 30, 2003
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Schedule of License Agreements [Line Items] | |||
| Payment Of License Fee | $ 10,000 | ||
| Payment Of Sublicense Fee Description | if the sublicense fee payable to the Company is between 4% and 5% of net sales, then the royalties payable to U. Mich. Shall be equal to 50% of the sublicense fee. | ||
| Percentage Of Revenue Received In Kind | 10.00% | ||
|
Minimum [Member]
|
|||
| Schedule of License Agreements [Line Items] | |||
| Future Milestone Payments | 100,000 | ||
|
Maximum [Member]
|
|||
| Schedule of License Agreements [Line Items] | |||
| Future Milestone Payments | 200,000 | ||
|
University Of Michigan Agreement [Member]
|
|||
| Schedule of License Agreements [Line Items] | |||
| Agreement Expiration Period | 2016 | ||
| Milestone Payment Method Description | if sales in the first 12 months are less than the amount of the milestone, then we are required to pay 50% of all sales until the milestone is satisfied. | ||
| Future Milestone Payments | 400,000 | ||
| Percentage Of Royalty Revenue | 3.00% | ||
| Percentage Of Reduction In Royalties Owed | 50.00% | ||
| Reimbursement Of Patent Maintenance Fees | 4,200 | 2,400 | |
|
University Of Michigan Agreement [Member] | New Drug Application [Member]
|
|||
| Schedule of License Agreements [Line Items] | |||
| Payment Of Milestone Expenses | $ 50,000 | ||
| Milestone Payment Method Description | such milestone fees may be deferred and paid within 12 months of the first commercial sale of such products | ||